Table 2.
Protein | Initial St. (G2) /Control (G1) |
Advanced St. (G2) /Control (G1) |
+ Curcumin (G3) /Initial St. (G2) |
+ Curcumin (G3) /Advanced St. (G2) |
---|---|---|---|---|
AP2S1 | 0.0040 | 0.0040 | 0.0003 | 0.0030 |
ARL2 | 0.0162 | ns (0.1091) | 0.0003 | 0.0148 |
DJB11 | 0.0040 | 0.0162 | 0.0003 | 0.0030 |
ECHA | 0.0040 | 0.0081 | 0.0002 | 0.0011 |
FABP5 | 0.0040 | 0.0283 | 0.0002 | 0.0070 |
FINC | 0.0040 | 0.0485 | 0.0019 | ns (0.1605) |
H2AJ | 0.0040 | 0.0081 | 0.0030 | ns (0.1949) |
HMCS2 | 0.0040 | ns (0.2828) | 0.0002 | ns (0.3823) |
HNRPK | 0.0040 | ns (0.1091) | 0.0002 | 0.0830 |
IDH3A | 0.0081 | ns (0.1535) | 0.0006 | 0.0047 |
LYPA1 | 0.0040 | 0.0040 | 0.0002 | 0.0003 |
NCPR | 0.0040 | 0.0040 | 0.0002 | 0.0002 |
PA2G4 | 0.0040 | 0.0162 | 0.0002 | 0.0650 |
PICAL | 0.0081 | 0.0485 | 0.0011 | 0.0379 |
PPAC | 0.0040 | 0.0040 | 0.0070 | 0.0104 |
SRSF2 | 0.0040 | ns (0.1091) | 0.0006 | ns (0.2345) |
VIME | 0.0040 | 0.0162 | 0.0019 | ns (0.5054) |
Proteins for which abundance decrease or increase within the G2 group (“Tumor”) does not follow tumor progression. Nonsignificant differences (ns) are indicated in italics with calculated p values in smaller characters in brackets. Tendencies are indicated in normal type, and bold type was used to draw attention to p values < 0.05. Full names of proteins are given in Tables S1 and S2.